• Curocell, Breaks Ground on 'CAR-T Manufacturing GMP Facility' prnasia
    December 24, 2021
    Curocell, currently on PhaseⅠCAR-T Therapy clinical trial with CRC01 (anbalcabtagene autoleucel) has recently broken ground for the new CAR-T Center in Dungok Residential & Industrial Area in Daejeon International Science & Business Belt.
PharmaSources Customer Service